Sutro Biopharma, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:STRO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 321.43 M262.36 M209.66 M173.83 M241.99 M Total liabilities 347.24 M294.47 M296.93 M306.28 M308.88 M Total equity -25.81 M-32.11 M-87.27 M-132.45 M-66.89 M Total liabilities & shareholders' equities 321.43 M262.36 M209.66 M173.83 M241.99 M Total debt ————— Net debt —————

News

MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates

Stock Picks From Seeking Alpha's April 2026 New Analysts

Ocugen (OCGN) Reports Q1 Loss, Beats Revenue Estimates

Sutro Biopharma Stock: Recycling Past Data Ahead Of The Readout (NASDAQ:STRO)

Sutro Biopharma, Inc. (STRO) Presents at AACR Annual Meeting 2026 - Slideshow (NASDAQ:STRO) 2026-04-24

Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last?

Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?

Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates

Sutro Biopharma, Inc. (STRO) Presents at 16th Annual World ADC London Summit - Slideshow (NASDAQ:STRO) 2026-02-28

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?

Sutro Biopharma prices $110 million common stock offering

Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock?